Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.03 USD
Change Today +0.03 / 1.50%
Volume 5.5K
IMI On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

intermolecular inc (IMI) Snapshot

Open
$2.05
Previous Close
$2.00
Day High
$2.05
Day Low
$2.01
52 Week High
09/4/14 - $2.49
52 Week Low
02/6/15 - $1.55
Market Cap
99.0M
Average Volume 10 Days
46.0K
EPS TTM
$-0.50
Shares Outstanding
48.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for INTERMOLECULAR INC (IMI)

intermolecular inc (IMI) Related Bloomberg News

View More Bloomberg News

intermolecular inc (IMI) Related Businessweek News

No Related Businessweek News Found

intermolecular inc (IMI) Details

Intermolecular, Inc. develops and applies high productivity combinatorial (HPC) research and development technologies for the semiconductor and clean energy industries worldwide. Its HPC platform includes wet processing tools that apply HPC methods to fluids-based applications, such as cleans, deposition and wet etch, self-assembly, and surface treatment processes; and dry processing tools, which apply HPC methods to vapor-based applications for primary, secondary, and tertiary screening. The company’s HPC platform also comprise automated characterization systems to characterize the substrates processed by Tempus HPC processing tools and generates experimental data while matching processing throughput; and informatics software, analysis, and services, including workflow management software, analysis and reporting software, security and collaboration management software, and integration services to automate experiment generation, characterization, data analysis, and reporting, as well as to create an aggregated and searchable database of information. It serves semiconductor device, semiconductor materials and equipment, and clean-energy companies. The company was formerly known as The BEP Group, Inc. and changed its name to Intermolecular, Inc. in November 2004. Intermolecular, Inc. was founded in 2004 and is headquartered in San Jose, California.

166 Employees
Last Reported Date: 02/27/15
Founded in 2004

intermolecular inc (IMI) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $131.9K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $333.1K
Senior Vice President of Business Operations ...
Total Annual Compensation: $71.5K
Vice-President of Finance and Corporate Contr...
Total Annual Compensation: $239.6K
Chief Technology Officer
Total Annual Compensation: $350.3K
Compensation as of Fiscal Year 2014.

intermolecular inc (IMI) Key Developments

Intermolecular, Inc. Reports Unaudited Consolidated Financial Results for the Second Quarter and Six Months Ended June 30, 2015; Provides Earnings Guidance for the Third Quarter of 2015

Intermolecular, Inc. reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported total revenue of $10,994,000 compared to $9,934,000 for the same period a year ago. Operating loss was $5,559,000 compared to $6,683,000 last year. Loss before provision for income taxes was $5,678,000 compared to $6,857,000 last year. Net loss was $5,680,000 or $0.12 per basic and diluted share compared to $6,859,000 or $0.15 per basic and diluted share last year. Non-GAAP operating loss was $3,812,000 compared to $5,085,000 last year. Non-GAAP net loss was $3,933,000 or $0.08 per diluted share compared to $5,261,000 or $0.11 per diluted share last year. For the six months, the company reported total revenue of $20,839,000 compared to $25,839,000 for the same period a year ago. Operating loss was $12,420,000 compared to $10,331,000 last year. Loss before provision for income taxes was $12,688,000 compared to $10,704,000 last year. Net loss was $12,673,000 or $0.27 per basic and diluted share compared to $10,710,000 or $0.23 per basic and diluted share last year. Net cash used in operating activities was $3,966,000 compared to net cash provided by operating activities was $659,000 last year. Purchase of property and equipment was $1,299,000 compared to $1,958,000 last year. Non-GAAP operating loss was $8,777,000 compared to $6,177,000 last year. Non-GAAP net loss was $9,030 or $0.19 per diluted share compared to $6,556,000 or $0.14 per diluted share last year. For the third quarter of 2015, the company projects revenue in the range of $10.5 to $11.5 million. Non-GAAP net loss, which excludes stock-based compensation expense, is projected between $4.0 million and $5.0 million, or between $0.08 to $0.10 per share, on approximately 49 million shares outstanding.

Intermolecular, Inc. to Report Q2, 2015 Results on Aug 06, 2015

Intermolecular, Inc. announced that they will report Q2, 2015 results at 5:00 PM, US Eastern Standard Time on Aug 06, 2015

Intermolecular, Inc., Q2 2015 Earnings Call, Aug 06, 2015

Intermolecular, Inc., Q2 2015 Earnings Call, Aug 06, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMI:US $2.03 USD +0.03

IMI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IMI.
View Industry Companies
 

Industry Analysis

IMI

Industry Average

Valuation IMI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.2x
Price/Book 1.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTERMOLECULAR INC, please visit www.intermolecular.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.